Additionally, the Gem-treated PRMT5 KO tumors exhibited a 30% reduction in tumor volume compared to the Gem-treated WT tumors (404.9 mm3 vs. 579.1 mm3, p = 0.046). Here, PRMT5 is linked to neoplasm.